TiGenix says additional data for stem cell product affirms safety profile
March 9, 2016Research and Development Crohn’s disease, TiGenix, crohn's disease, drug trial
Belgian biotech firm TiGenix said the results of a 52-week follow-up study of its trial drug for a stem-cell condition …
Merck chief executive Karl-Ludwig Kley to step down in April
March 9, 2016Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley
It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
French clinical trial tragedy “astonishing and unprecedented”, says report
March 9, 2016Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy
A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …
Ipsen and PeptiMimesis announce oncology research partnership
March 9, 2016Research and Development INSERM, PeptiMimesis, ipsen, peptides
Specialist pharma company Ipsen is partnering with French start-up PeptiMimesis to develop and market of novel therapeutic peptides in oncology. …
Crown Bioscience expands portfolio with PreClinOmics acquisition
March 9, 2016Manufacturing and Production, Research and Development cardiovascular, collaboration, crown bioscience, metabolic, preclinomics
Crown Bioscience has announced the acquisition of PreClinOmics, which will see the US-based drug discovery solutions company expand its cardiovascular …
MSD joins charity-industry partnership Dementia Consortium
March 9, 2016Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium
The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …
AZ drug gets orphan status for rare inflammatory disease
March 9, 2016Research and Development AstraZeneca, MEDI-551, MedImmune, orphan drug
AstraZeneca’s biologics R&D arm MedImmune has been granted Orphan Drug Designation by the FDA for its investigational anti-CD19 monoclonal antibody, …
Genmab ends ofatumumab trials for autoimmune conditions; to focus on multiple sclerosis
March 9, 2016Research and Development Arzerra, GSK
Danish drug-company Genmab (Nasdaq Copenhagen: GEN) said it will discontinue the late-stage trials for Arzerra (ofatumumab) to develop a treatment for …
Medimmune gets US FDA fast track designation for flu drug
March 9, 2016Research and Development
UK drug major AstraZeneca (LSE: ANZ) said its biologics R&D unit, MedImmune, has received Fast Track designation from the US …
Groundbreaking Ceremony of SHL Group New Site
March 9, 2016Manufacturing and Production
In Q1 2018, all administrative offices and parts of the production will be relocated to the new site. The ground …
Bayer to collaborate on new treatments for tuberculosis with Universities of Dundee, Cape Town
March 8, 2016Manufacturing and Production, Research and Development Bayer, TB, tuberculosis, university of cape town, university of dundee
The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …
Amgen open to larger M&A deals, says CFO
March 8, 2016Sales and Marketing Amgen, mergers and acquisitions
Amgen’s chief financial officer has indicated that the company is ready to consider doing larger deals to buy other companies, …
Sanofi Pasteur and MSD end European vaccines partnership
March 8, 2016Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines
Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
Kuros Biosciences re-appoints chief medical officer
March 8, 2016Medical Communications
Kuros Biosciences has announced the appointment of Dr Virginia Jamieson as chief medical officer and member of the executive board …
Novartis and Microsoft team up for Kinect collab
March 8, 2016Manufacturing and Production, Research and Development Microsoft, Novartis, multiple sclerosis
Novartis has partnered with technology giant Microsoft; hoping to use its Kinect motion sensor to quantify whether its multiple sclerosis …
Merck posts 15% rise in Q4 profits driven by Sigma-Aldrich acquisition
March 8, 2016Manufacturing and Production, Sales and Marketing
German drug maker Merck on Tuesday said it sees the acquisition of Sigma-Aldrich to aid sales in 2016 and reported …
Wireless contact lens sensor approved by FDA
March 8, 2016Manufacturing and Production, Research and Development, Sales and Marketing
The US Food and Drug Administration has allowed the marketing of a contact lens sensor that may help practitioners identify …
AbbVie pays $595m upfront for experimental Boehringer psoriasis drug
March 8, 2016Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, BI 655066, Boehringer Ingelheim, psoriasis
AbbVie is betting big on the future of an experimental psoriasis drug, paying $595m upfront for the rights to Boehringer …
Shares in Celldex halve in value as it discontinues trial of brain cancer drug
March 8, 2016Manufacturing and Production, Research and Development Cancer, Celldex, research
Shares in Celldex Therapeutics (Nasdaq: CLDX) more than halved in value on the Nasdaq Monday as the company said independent regulators …
Onconova says Baxalta ends $565 million drug development deal for rigosertib
March 8, 2016Manufacturing and Production, Research and Development Baxalta, Onconova Therapeutics, drug development, rigosertib
Onconova Therapeutics says Baxalta has terminated its $565 million agreement to jointly develop the company’s lead drug candidate rigosertib. Baxalta …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
